Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite.
COVID-19 caused the world to change abruptly, as people scrambled to accommodate new strictures and shifting expectations. Masks and social distancing became commonplace—and around the world, businesses learned how to adapt to patrons who refused to leave their homes. Delivery services flourished. Work became remote. Gatherings of all kinds moved online.
Even as societies reopen, many of these innovations remain in place. People enjoy the convenience. For many industries, these changes are now the new normal.
They certainly are for the clinical trial industry. Several forces have converged to make this the case, including the escalation of mobile research nursing.
Even before the pandemic, the rise of patient-centered care combined with burgeoning mHealth technology options fed an increasing interest in decentralized trials. In this format, instead of requiring patients to trek to a large research hospital—possibly in a distant town—tests are performed, therapies administered, and data collected closer to the patient’s home. Researchers partn...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).